NFL BIOSCIENCES (EPA:ALNFL)

BRIEF

published on 09/27/2024 at 17:50, 2 months 24 days ago

NFL BIOSCIENCES: 2024 First-Half Business and Earnings Update

Capital Increase NFL-101 Phase 3 Trial NFL-301 Clinical Developments
REGULATED PRESS RELEASE

published on 09/27/2024 at 17:45, 2 months 24 days ago

NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
NFL Biosciences reports 2024 first-half business and earnings update, showcasing advancements in smoking cessation drug candidate NFL-101 and alcohol consumption drug candidate NFL-301

NFL Biosciences Smoking Cessation Botanical Drugs 2024 First-half Earnings Alcohol Consumption
REGULATED PRESS RELEASE

published on 09/27/2024 at 17:45, 2 months 24 days ago

NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1er SEMESTRE 2024
NFL Biosciences présente ses avancées dans le développement de médicaments pour le sevrage tabagique et la réduction de la consommation d’alcool, ainsi que ses résultats financiers du 1er semestre 2024

Résultats Financiers NFL Biosciences Sevrage Tabagique Médicaments Alcool
REGULATED PRESS RELEASE

published on 09/09/2024 at 17:45, 3 months 12 days ago

NFL BIOSCIENCES : AGENDA DE PARTICIPATION ÉVÉNEMENTS PHARMA ET INVESTISSEURS INSTITUTIONNELS
REGULATED PRESS RELEASE

published on 09/09/2024 at 17:45, 3 months 12 days ago

NFL BIOSCIENCES: PARTICIPATION CALENDAR PHARMA EVENTS AND INSTITUTIONAL INVESTORS
REGULATED PRESS RELEASE

published on 07/15/2024 at 08:00, 5 months 6 days ago

NFL BIOSCIENCES : RÉSULTATS DE L’ÉTUDE CESTO II
REGULATED PRESS RELEASE

published on 07/15/2024 at 08:00, 5 months 6 days ago

NFL BIOSCIENCES: CESTO II STUDY RESULTS
REGULATED PRESS RELEASE

published on 07/11/2024 at 17:45, 5 months 10 days ago

NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ DU 1er SEMESTRE 2024
BRIEF

published on 06/17/2024 at 11:05, 6 months 4 days ago

NFL BIOSCIENCES : publication scientifique de l'étude sur le mécanisme d'action de NFL-101 menée par le CEA dans ACS Chemical Neuroscience

NFL Biosciences NFL-101 CEA Étude Scientifique ACS Chemical Neuroscience
BRIEF

published on 06/17/2024 at 11:05, 6 months 4 days ago

NFL BIOSCIENCES Publishes Study on NFL-101 Mechanism of Action

Smoking Cessation NFL-101 Scientific Research ACS Chemical Neuroscience Mechanism Of Action

Published on 12/21/2024 at 01:30, 1 day 4 hours ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 4 hours ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 5 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 1 day 6 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 1 day 6 hours ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 1 day 5 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 1 day 5 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 11 hours ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 17 hours 44 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 17 hours 44 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 12 hours ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News